Table 3 Individual characteristics, diagnostic results and outcome of the suspected cases of commensal oropharyngeal flora caused hospital-acquired pneumonia and community-acquired pneumonia

24

M

Respiratory failure

37.4

COF 10⁵

Specimen storage lacking

COF heavy

Piper/tazob −6 -1

Multiple myeloma. Post-mortem exam: CMV pneumonia. Candida spp.

CMV pneumonia

1^a

65

33.0

C. glabrata 10³

Metronidazole −11 -1

Fluconazole −11-1

25

M

Respiratory failure

0.0

COF 10⁵

No growth

E. coli moderate

None

Immunosuppresive drug after lung transplantation. Ventilator depended after discharge

COF-HAP

182

41

60.0

OF rare

26

F

Neurological

4.8

COF > 10⁵

N. subflava 4*10²

COF few

Amoxi/clav acid −2 -5

Possible aspiration Post-mortem exam: Indicative for amiodarone induced pneumonitis (AIP)

AIP

10^a

73

63.8

S. anginosus 3*10²

S. mitis/oralis 3*10²

H. influenzae 2*10²

27

M

Hypokalemia

0.0

COF 10⁵

E. faecium 4*10⁴

No growth

Ciprofloxacin −2 -2

Acute myeloid leukemia. RSV ct 20, HSV-1 ct 29

RSV CAP/ E. faecium HAP

29^a

60

96.8

S. epidermidis 3*10⁴

Piper/tazob −2-18

Vancomycin 1-26

28

M

Respiratory failure

0.0

COF 10⁴

C. jeikeium 5*10³

Candida spp.

Piper/tazob −11 -0

B-cel Lymphoma

COF-HAP

16^a

50

11

E. faecium 4*10³

Meropenem 0-16

29

M

Respiratory failure

0.0

COF 10⁵

E. faecium 2*10⁴

COF few

Piper/tazob −2 -15

Acute myeloid leukemia

COF-HAP

31^a

54

0.8

Vancomycin 4-12

Possible aspiration.

HSV-1 ct 34

30

F

Sepsis

0.0

COF 10⁴

No growth

NP

Amoxi/clavc acid 0-1

Metastatic mammacarcinoma

COF-CAP

1^a

48

21.4

Ciprofloxacin 0-1

31

M

Respiratory failure

0.2

COF 10⁴

A. viscosus

COF rare

Co-trimoxazole −20 -27

Idiopathic CD4 deficiency. ICU admission for BAL only. P. jiroveci ct 24.

PcP

0

68

32.8

R. mucilaginosa

S. mutans